INTRODUCTION
Phospholipase D (PLD) cleaves phosphatidylcholine in response to a variety of cell stimuli to generate phosphatidic acid, which is associated with a number of cellular responses including regulated secretion, cytoskeletal reorganization, proliferation and meiosis [1, 2] . Phosphatidic acid is also known to activate directly phosphatidylinositol-4-phosphate-5-kinase type I [3] , mammalian target of rapamycin (' mTOR ') [4] and many other enzymes in itro and in i o [5, 6] . However, the physiological roles of phosphatidic acid are not fully elucidated. Two mammalian PLD genes, PLD1 and PLD2, have been cloned [7] . PLD1 is regulated by low-molecular-mass GTP-binding proteins such as ADP-ribosylation factor and the Rho family GTPbinding protein and also by protein kinase C. On the other hand, the mechanisms that regulate PLD2 activity are still undefined in i o, although PLD2 is constitutively active and requires PtdIns(4,5)P # in itro [1, 2, [5] [6] [7] . Recent studies have shown that overexpression of PLD1 and PLD2 in transformed cells stimulates cell proliferation and generates a survival signal that overcomes the apoptotic signals [6, 8] . On the other hand, Lee et al. [9] have demonstrated that PLD2-overexpression reduced Abbreviations used : CHO, Chinese hamster ovary ; EDG, endothelial differentiation gene ; ERK, extracellular signal-regulated kinase ; GPCR, G-protein-coupled receptor ; IGF, insulin-like growth factor ; PBut, phosphatidylbutanol ; PI 3-kinase, phosphoinositide 3-kinase ; PLD, phospholipase D ; PLD1KR, K898R mutant of PLD1 ; PLD2KR, K758R mutant of PLD ; PLD1WT and PLD2WT, wild-type PLD1 and PLD2 respectively ; S1P, sphingosine 1-phosphate. 1 To whom correspondence should be addressed (e-mail banno!cc.gifu-u.ac.jp).
cells. Overexpression of wild-type PLD1 and PLD2 substantially potentiated S1P-, but not IGF-I-, induced activation of PI 3-kinase and Akt, whereas overexpression of the catalytically inactive mutant of PLD1 or PLD2 did not affect the responses to either agonist. On the other hand, overexpression of wild-type PLD1 and PLD2 potentiated IGF-I-and, to much smaller extents, S1P-induced ERK stimulation. ERK activation by IGF-I as well as S1P was dependent on Ras, but Akt activation by IGF-I was not dependent on Ras. These results suggest that PLDs are involved in growth factor regulation of at least two signalling pathways, PI 3-kinase\Akt and ERKs, depending on the class of cell-surface receptors.
Key words : CHO-K1 cells, extracellular signal-regulated kinase (ERK), insulin-like growth factor-I (IGF-I), phosphoinositide 3-kinase (PI 3-kinase), sphingosine 1-phosphate. extracellular signal-regulating kinase (ERK) activation and negatively regulated mitogen signalling. However, little information is available about the mechanism of PLD activation in cell survival signalling.
Much evidence suggests that sphingosine 1-phosphate (S1P) is a member of a new class of lipid second messengers derived from sphingolipid metabolism [10] . Recently, five closely related G-protein-coupled receptors (GPCRs) of the endothelial differentiation gene (EDG) family (namely EDG1\S1P " , EDG3\S1P $ , EDG5\S1P # , EDG6\S1P % and EDG8\S1P & ) were identified as plasma membrane receptors for S1P [11, 12] . The potential roles of S1P in cellular growth and survival have also been suggested by its ability to decrease ceramide-and serum-withdrawalinduced apoptosis [13, 14] . ERK, as well as Akt, is implicated in cell proliferation and survival signalling. Recent studies have demonstrated that PLD2, as well as PLD1, plays a role in insulin and lysophosphatidic acid receptor-mediated activation of ERK via Raf-1 translocation to membrane [15, 16] . Our previous study has demonstrated that PLD was involved in EDG3\S1P $ -mediated, S1P-induced phosphoinositide 3-kinase (PI 3-kinase)\ Akt activation in Chinese hamster ovary (CHO) cells [17] . It is known that insulin-like growth factor (IGF) strongly activates PI 3-kinase in CHO cells [18] . It was shown previously that GPCR-mediated activation of PI 3-kinase mechanistically differs from that mediated by receptor tyrosine kinases [19, 20] . In this study, we have examined whether PLDs are involved in IGF-Iinduced activation of PI 3-kinase\Akt and ERK.
MATERIALS AND METHODS

Materials
Geneticin (G418) and PMA were obtained from Sigma (St. Louis, MO, U.S.A.); pCMV-zeo and Zeocin were from Invitrogen (Groningen, The Netherlands); S1P was from Matreya Polyclonal anti-PLD1 and -PLD2 antibodies were prepared as described previously [21] . Anti-rabbit and anti-mouse antibodies conjugated with horseradish peroxidase and the chemiluminescence kit (ECL2 system) were obtained from Amersham Biosciences (Little Chalfont, Bucks., U.K. 
Cell culture and transfections
CHO-K1 cells overexpressing S1P $ (S1P $ -CHO cells) were cultured in Ham's F-12 medium supplemented with 10 % (v\v) fetal bovine serum, 100 units\ml penicillin G, 100 µg\ml streptomycin and 0.75 mg\ml G418 as described previously [22] . For stable transfection of PLD1 and PLD2, S1P $ -CHO cells were plated at 8i10& in 60 mm plates and cultured for 24 h prior to transfection. Cells were incubated for 4 h with 2 ml of serum-free Ham's F-12 medium containing 1.05 µg of total plasmid DNA (1 µg of pCGN-wild-type or inactive mutants of PLDs and 0.05 µg of pCMV-Zeo), and 5 µl of AMINE4 (Gibco Life Technologies). Stable transfections were selected in the presence of 0.7 mg\ml G418 and 0.5 mg\ml Zeocin, and expanded for further analysis under selective conditions. Replication-deficient adenovirus encoding N"(-Ras was generated and amplified as described previously [22] . The cells were infected with adenovirus and cultured for 48 h. The cells were serumstarved in serum-free Ham's F-12 medium for 24 h before stimulation assay. Role of phospholipase D in extracellular signal-regulated kinase activation
Measurement of PLD activity
Subconfluent cells were labelled for 24 h with 1 µCi\ml [$H]palmitic acid in serum-free Ham's F-12 medium. Cells were washed and preincubated in Hepes-Tyrode buffer containing 0.3 % butan-1-ol (v\v) for 10 min. Following stimulation of cells with S1P or PMA, the reactions were terminated by removing the assay buffer, followed by immediate addition of 1 ml of an ice-cold PBS\methanol (2 : 5, v\v) mixture to the culture dishes. After extraction of cellular lipids, [$H]phosphatidylbutanol (PBut) was separated by TLC and measured as described previously [21] .
Western blot analysis
Cells were grown in 100 mm dishes to subconfluence and further incubated in serum-free Ham's F-12 medium for 24 h. Washed cells were then stimulated, harvested in an ice-cold lysis buffer (1 % Nonidet P-40, 0.5 % sodium cholate, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 20 mM Hepes, 3 mM MgCl # , 1 mM PMSF, 20 µg\ml leupeptin, 20 mM β-glycerophosphate, 1 mM NaF and 1 mM sodium orthovanadate, pH 7.4) and sonicated. Protein concentrations were assayed using the Bradford protein assay reagent (Bio-Rad) with BSA as a standard. Total cell lysates (50 µg of protein) were subjected to SDS\PAGE (10 % gel) and transferred to PVDF membranes (Millipore). The membranes were blocked with 5 % BSA. Phosphorylation of Akt or ERK and the total amounts of Akt and ERK were determined by immunoblotting with rabbit polyclonal anti-phospho-specific Akt (Ser%($) or anti-phospho-specific ERK1\2, and anti-Akt or anti-ERK antibodies respectively, and with horseradish peroxidase-linked secondary antibody. After repeated washings, the antibodies were detected using the ECL Western blotting detection system.
PI 3-kinase assay
PI 3-kinase activity was carried out as described previously [23] . The immunoprecipitation was performed with PI 3-kinase p110α, p110β, p110γ or phosphotyrosine (PY-20) antibodies, and the PI 3-kinase activity was assayed using phosphatidylinositol as substrate.
RESULTS AND DISCUSSION
To understand roles of PLD isozymes in S1P-and IGF-Iinduced survival signalling, we established S1P $ -CHO cells overexpressing PLD isoforms. The cells that overexpressed PLD isozymes were generated by stable transfection with expression vectors containing the cDNAs encoding wild-type PLD1 and PLD2 (PLD1WT and PLD2WT respectively), and catalytically inactive PLD1KR and PLD2KR, and subsequent selection performed as described in the Materials and methods section. Cells transfected with an empty vector served as controls in all subsequent experiments. Western blot analysis with specific anti-PLD1 and anti-PLD2 antibodies showed overexpression of each of PLD1WT, PLD1KR, PLD2WT and PLD2KR ( Figure 1A) .
To examine functional activities of expressed PLD isozymes, we determined cellular PLD activity by measuring the formation of PBut in the presence of butan-1-ol via the transphosphatidylation reaction in [$H]palmitic acid-prelabelled cells. As shown in Figure 1(B) , the unstimulated basal PBut formation in the cells overexpressing PLD1WT was 2-fold higher than in the vector control cells. We previously showed that both S1P and PMA stimulated PLD activity in CHO cells [17] . In PLD1WT-overexpressing cells S1P-and PMA-stimulated PBut formation was 5-6-fold potentiated compared with the vector control cells.
Figure 2 S1P-or IGF-I-induced PI 3-kinase activation in vector control or PLD-overexpressing S1P 3 -CHO cells
Prior to stimulation with agonists, S1P3-CHO cells were incubated in serum-free medium for 24 h. (A) The vector cell lysates were then subjected to Western blot analysis with PI 3-kinase p110α, p110β or p110γ antibodies. (B) The vector cells were stimulated without or with 1 µM S1P or 100 ng/ml IGF-I for 5 min, and subjected to immunoprecipitation with anti-PI 3-kinase p110α or p110β, or PY-20 (P-Tyr) antibodies. (C) The vector control and PLD-overexpressing cells were stimulated without or with 1 µM S1P or 100 ng/ml IGF-I for 5 min, and subjected to immunoprecipitation with anti-PY-20 (P-Tyr) antibody. The immuncomplexes were assayed for PI 3-kinase activity as described in the Materials and methods section. The results shown are representative of three independent experiments.
In PLD2WT-overexpressing cells as well, both the basal and stimulated PBut formation was 2.5-4-fold potentiated compared with the vector control cells ( Figure 1B) . In contrast, in the cells overexpressing either PLD1KR or PLD2KR the basal PBut formation was slightly suppressed, although stimulated PBut formation was essentially similar in magnitude to that observed in the vector control cells. In the vector control cells IGF-I (100 ng\ml) stimulated PBut formation only slightly (1.5-fold), which was less than that observed with S1P ( Figures 1B  and 1C ). In the cells overexpressing either PLD1WT or PLD2WT, IGF-I-induced PBut formation was substantially potentiated but was still lower than that with S1P stimulation, whereas in the cells overexpressing either PLD1KR or PLD2KR the level of IGF-I-induced PBut formation was similar to that in the vector control cells.
Our previous study demonstrated that S1P-induced PLD activation via the GPCR S1P $ was involved in S1P-induced stimulation of the PI 3-kinase\Akt survival signalling pathway [17] . However, it is not known whether PLD is also involved in receptor tyrosine kinase-mediated activation of PI 3-kinase and its downstream effector Akt. We therefore examined the involvement of PLD1 and PLD2 in IGF-I-induced stimulation of PI 3-kinase and Akt. S1P $ -CHO cells exhibited abundant PI 3-kinase activities associated with anti-p110α and anti-p110β immunoprecipitates, but not with anti-p110γ immunoprecipitates (Figure 2A ). IGF-I (100 ng\ml) induced robust stimulation of PI 3-kinase activities associated with anti-p110α, anti-p110β or anti-phosphotyrosine immunoprecipitates (Figure 2B) . In contrast, the optimal concentration of S1P (1 µM) weakly stimulated PI 3-kinase activities associated with only anti-p110β and anti-phosphotyrosine immunoprecipitates. IGF-I-stimulated PI 3-kinase activity associated with antiphosphoptyrosine immunoprecipitates in either PLD1WT-or
Figure 3 Effect of overexpression of PLD1 or PLD2 on agonist-stimulated phosphorylation of Akt
Prior to stimulation with agonists, S1P 3 -CHO cells were incubated in the serum-free medium for 24 h. The vector control or PLD1WT-or PLD2WT-overexpressing cells were stimulated without or with 1 µM S1P or 100 ng/ml IGF-I for 5 min, and the cell lysates were then subjected to Western blot analysis using antibodies of phospho-specific Akt or Akt as described in the Materials and methods section. The results from the Western blots are representative of three independent experiments. The data expressed as arbitrary units are meanspS.E.M. from three different experiments.
Figure 4 Effect of overexpression of PLD1 or PLD2 on agonist-stimulated ERK phosphorylation
Prior to stimulation with agonists, S1P 3 -CHO cells were incubated in the serum-free medium for 24 h. The vector control or PLD-overexpressing cells were stimulated without or with 1 µM S1P or 100 ng/ml IGF-I for 5 min, and the cell lysates were then subjected to Western blot analysis using antibodies of phospho-specific ERK or ERK as described in the Materials and methods section. The results of Western blots are representative of three independent experiments. The data are meanpS.E.M. from three different experiments.
PLD2WT-overexpressing cells was not different from that in the vector control cells ( Figure 2C ). In contrast, S1P-stimulated PI 3-kinase activity in cells overexpressing either PLD1WT or PLD2WT was considerably enhanced compared with the vector control cells.
We next examined the effect of overexpression of PLDs on stimulation of Akt. In the vector control cells, IGF-I (100 ng\ml) stimulated Akt 4-fold more strongly than S1P (1 µM), as estimated by Western blot analysis of Ser%($ phosphorylation of Akt (Figure 3 ). In the cells overexpressing PLD1WT or PLD2WT, IGF-I-induced Akt stimulation was similar to that in the vector control cells (Figure 3, right-hand panel) , which was in agreement with the results of IGF-I-induced PI 3-kinase stimulation ( Figure 2C ). On the other hand, S1P-induced Akt stimulation in the cells overexpressing PLD1WT or PLD2WT was potentiated compared with the vector control cells (Figure 3 , left-hand panel), which was consistent with our previous observation that transient overexpression of either PLD1WT or
Figure 5 Effects of butan-1-ol and butan-2-ol on IGF-I-induced Akt and ERK activation in S1P 3 -CHO cells
Before stimulation with 100 ng/ml IGF-I for 5 min, S1P3-CHO cells were incubated with butan-1-ol (0.3 %) or butan-2-ol (0.3 %) for 20 min. The cell lysates were subjected to 10 % PAGE and blotted with anti-phospho-Akt, -Akt, -phospho-ERK or -ERK antibodies as described in the Materials and methods section. The results of the Western blots are representative of three independent experiments. The extent of phosphorylation was quantified by densitometer and expressed as the meanspS.E.M. from three different experiments.
PLD2WT potentiated S1P-induced Akt stimulation [17] . Thus different from the case of S1P stimulation of the GPCR S1P $ , neither PLD1 nor PLD2 seems to be involved in IGF-I receptor tyrosine kinase-mediated stimulation of PI 3-kinase and the downstream effector Akt.
There are some reports suggesting that PLDs are also involved in extracellular ligand-induced activation of ERKs, another
Figure 6 Effect of LY29004 and dominant-negative Ras on IGF-I-induced Akt or ERK activation in S1P 3 -CHO cells
Prior to stimulation with agonists, S1P 3 -CHO cells were incubated in the serum-free medium for 24 h. (A) S1P 3 -CHO cells were treated with or without 20 µM LY29004 for 15 min, and stimulated with 100 ng/ml IGF-I for 5 min. (B) S1P3-CHO cells were transiently transfected with Asn 17 -H-Ras (N 17 -Ras ; dominant negative) expression vector, and then stimulated without or with 100 ng/ml IGF-I for 5 min. Cell lysates were subjected to Western blot analysis using antibodies for phospho-specific Akt, phospho-specific ERK, Akt or ERK as described in the Materials and methods section. The results of Western blots are representative of three independent experiments. The data expressed as arbitrary units are meanspS.E.M. from three different experiments.
survival signalling pathway [15, 16] . Therefore, we next examined the involvement of PLD1 and PLD2 in IGF-I-and S1P-induced ERK activation in CHO cells. In the vector control cells both S1P (1 µM) and IGF-I (100 ng\ml) induced ERK stimulation as estimated with Western analysis of Tyr#!% phosphorylation of ERK1 and ERK2 (Figure 4) . S1P was more effective in stimulating ERKs than IGF-I. S1P-induced ERK activation in the cells expressing either PLD1WT or PLD2WT was slightly (15-20 %) augmented compared with the vector control cells (Figure 4, left-hand panel) . On the contrary, IGF-I stimulation of ERKs in cells expressing either PLD1WT or PLD2WT was markedly (2.5-3-fold) enhanced compared with the vector control cells (Figure 4, right-hand panel) . This potentiating effect of PLDs on IGF-I stimulation of ERKs was in contrast with the cases of IGF-I stimulation of PI 3-kinase and Akt (Figures 2  and 3) .
To confirm the involvement of PLD in this survival signalling, the effects of butanol on IGF-I-induced Akt and ERK signalling pathways were examined in the vector control cells. As shown in Figure 5 , the IGF-I-induced ERK activation was suppressed by butan-1-ol, but not butan-2-ol ( Figure 5 , right-hand panel). On the other hand, neither butanol had an effect on IGF-I-induced Akt phosphorylation ( Figure 5 , left-hand panel). Our previous study demonstrated that S1P-induced stimulation of the PI 3-kinase\Akt was suppressed by butan-1-ol, but not butan-2-ol [17] . S1P-induced ERK activation was inhibited, but to a lesser extent, by butan-1-ol (results not shown). These results were completely in agreement with the observations obtained using overexpression of PLDs, suggesting that PLD is involved in the IGF-I-induced ERK activation pathway, but not in the Akt pathway, in S1P $ -CHO cells. To understand the mechanisms underlying the different involvement of PLDs in S1P-and IGF-I-mediated stimulation of ERK, we examined the involvement of PI 3-kinase and the small GTPase Ras, which are known upstream intermediates for cellsurface receptor-mediated ERK activation. Although the PI 3-kinase inhibitor LY29004 abrogated IGF-I-induced Akt activation, it did not inhibit ERK activation ( Figure 6A ). LY29004 had also no effect on S1P-mediated ERK activation (results not shown). We showed previously that expression of a dominant negative mutant of H-Ras, N"(-Ras, abolished S1P-induced ERK activation in S1P $ -CHO cells [24] , indicating dependence of S1P-induced ERK1\2 stimulation on Ras. We observed in the present study that adenovirus-mediated expression of N"(-Ras abolished IGF-I-induced ERK activation ( Figure 6B , right-hand side), indicating that IGF-I stimulation of ERK1\2 is also Rasdependent. These observations may suggest that PLDs are involved in IGF-I-induced, but not S1P-induced, Ras activation, or that PLDs participates specifically in IGF-I-induced ERK stimulation at a site(s) downstream or independent of Ras. Furthermore, to investigate the mechanism underlying the distinct dependence on PLDs of IGF-I-induced stimulation of ERKs and PI 3-kinase\Akt, we examined the effect of N"(-Ras expression on IGF-I stimulation of Akt. As shown in Figure 6 (B) (left-hand side), N"(-Ras expression did not affect IGF-I-induced Akt activation, indicating that IGF-I-stimulation of Akt is independent of Ras. Thus Akt and ERKs differ in their requirement of Ras for IGF-I-induced activation. This observation may favour the possibility that PLDs could be involved in IGF-I-induced Ras activation and consequently in IGF-Iinduced ERK activation.
In conclusion, the present study demonstrated that PLDs are differentially involved in the GPCR S1P $ and IGF-I receptor tyrosine kinase-mediated activation of the survival signalling pathways, PI 3-kinase\Akt and ERKs. Thus PLDs affect the activities of at least two cellular targets for regulating the cell survival signalling pathways. The involvement of PLDs in the stimulatory regulation of PI 3-kinase and ERKs is dependent on the cell context, particularly the class of activated cell-surface receptors which a growth factor acts on to convey stimulatory signals into the survival signalling pathway. The exact molecular mechanisms underlying the observations remain to be fully clarified.
